Histamine

Histamine

SCHEMBL123245

NCCc1cnc[nH]1.O=P(O)(O)O.O=P(O)(O)O

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HRH1

The experimentally established mechanism targets of Histamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HRH1 known ✓ P35367 8/20 0.78
HRH3 Q9Y5N1 8/20 0.78
HRH4 Q9H3N8 7/20 0.78
HRH2 P25021 4/20 0.78
TSHR P16473 2/20 0.78
LMNA P02545 1/20 0.78
MIF P14174 1/20 0.78
APEX1 P27695 1/20 0.75
SMN1; SMN2 Q16637 1/20 0.75
FDPS P14324 1/20 0.58
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C19 P33261 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Histamine SCHEMBL27939119 0.98 HRH3 (0.75) HRH3HRH1HRH4HRH2TSHR
Histamine SCHEMBL288432 0.88
Histamine SCHEMBL16778301 0.86 HRH3 (1.00) HRH3HRH1HRH4HRH2TSHR
Histamine SCHEMBL17377087 0.86
Histamine SCHEMBL3960364 0.81 HRH3 (0.70) HRH3HRH1HRH4HRH2TSHR
Homohistamine SCHEMBL2092691 0.76
SCHEMBL12350204 0.75 QPCT (0.57) HRH3HRH1HRH4HRH2TSHR
SCHEMBL8963903 0.75 HRH3 (0.73) HRH3HRH1HRH4HRH2TSHR
Imbutamine SCHEMBL28015739 0.75 HRH3 (1.00) HRH3HRH1HRH4HRH2TSHR
Homohistamine SCHEMBL9799515 0.75 HRH3 (0.96) HRH3HRH1HRH4HRH2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2951 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115985521-B Qingkailing injection anaphylactic reaction detection model GUANGZHOU BAIYUN SHAN MING XING PHARMACEUTICAL Co.,Ltd. (CN) 2026-05-26 CN claimed
CN-120023897-A Preparation method and application method of sugar amine phosphorus-based wood modifier 东北林业大学 2025-05-23 CN claimed
CN-119139217-A Histamine sustained-release dopamine-hyaluronic acid injectable hydrogel, preparation method and application 复旦大学附属中山医院 2024-12-17 CN claimed
CN-119074936-A Medicine-carrying nano carbon dot for treating atherosclerosis and preparation method thereof 四川大学 2024-12-06 CN claimed
CN-118419869-A Bi (I) containing bismuth, phosphorus and nitrogen material, preparation method and application 德清县浙工大莫干山研究院 2024-08-02 CN claimed
CN-116081616-B Low-sulfur high-expansion-temperature expandable graphite and preparation method and application thereof 湛江市聚鑫新能源有限公司 2024-06-11 CN claimed
CN-115895723-B Method and system for continuously producing base oil from waste mineral oil containing chlorine and silicon 宁波中循环保科技有限公司 2024-06-04 CN claimed
WO-2024092841-A1 METHOD AND SYSTEM FOR CONTINUOUSLY PRODUCING BASE OIL FROM WASTE MINERAL OIL CONTAINING CHLORINE AND SILICON 宁波中循环保科技有限公司 2024-05-10 WO claimed
CN-117842968-A Biomass hard carbon sodium-electricity negative electrode material with enlarged interlayer spacing, preparation method and application 福建容钠新能源科技有限公司 2024-04-09 CN claimed
CN-117752785-A Histamine human immunoglobulin preparation and its preparing method 华兰生物工程重庆有限公司 2024-03-26 CN claimed
US-5261876-A Enhanced peritoneal membrane plasmapheresis MONCRIEF-POPOVICH RESEARCH INSTITUTE, INC. (US) 1993-11-16 US claimed
US-5176912-A Method of treating psoriasis CABEZAS ORESTES (US) 1993-01-05 US claimed
EP-0259438-A4 METHODS AND MATERIALS FOR TREATMENT OF RHEUMATOID ARTHRITIS. MCMICHAEL JOHN 1989-09-11 EP claimed
EP-0094575-B1 COMPOSITIONS FOR TREATMENT OF DISEASE STATES INVOLVING IMMUNOLOGICAL FACTORS MCMICHAEL, John (US) 1988-08-10 EP claimed
EP-0259438-A1 METHODS AND MATERIALS FOR TREATMENT OF RHEUMATOID ARTHRITIS MCMICHAEL, John (US) 1988-03-16 EP claimed
US-4705685-A Methods and materials for treatment of disease states involving immunological factors SIGNAL COORDINATING THERAPY, INC. 1987-11-10 US claimed
US-4704273-A IMMUNOGLOBULIN G PROVOCATIVE OF PHEUMATOID FACTOR FORMATION MOLECULAR RX, INC. 1987-11-03 US claimed
WO-1987005221-A1 METHODS AND MATERIALS FOR TREATMENT OF RHEUMATOID ARTHRITIS MCMICHAEL JOHN 1987-09-11 WO claimed
US-4521405-A MIXTURE OF HISTAMINE AND MEASLES VIRUS IMMUNMOGEN McMichael, John (US) 1985-06-04 US claimed
EP-0094575-A2 Compositions for treatment of disease states involving immunological factors MCMICHAEL, John (US) 1983-11-23 EP claimed